MSOS's metric understates risk by excluding large tax liabilities, especially for CURLF and TCNNF. Learn more about the MSOS ...

Cannabis multi-state operators, which surged Wednesday following a report that marijuana would be reclassified as a Schedule ...

AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs) and the largest asset manager of U.S. and global cannabis stocks, today issued the following statement in response to ...

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in underlying equities. The contraction of the product lineup has left a smaller ...

MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and ...

The change does not legalize marijuana but reduces regulatory hurdles and offers tax relief for licensed operators. ・Trump ...

Sun, January 18, 2026 at 3:59 PM UTC The AdvisorShares Pure US Cannabis ETF has spent the last month on a rollercoaster. After climbing to $6.45 in mid-December 2025, shares dropped 26% to around ...

Amplify Alternative Harvest ETF (NYSEMKT: MJ) targets the broader global cannabis market -- with a heavy weighting on ...

Investors in Advisorshares Trust Advisorshares Pure US Cannabis (Symbol: MSOS) saw new options begin trading today, for the February 25th expiration. At Stock Options Channel, our YieldBoost formula ...

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report. Re-scheduling ...